ADPKD with Liver Cyst Infection and Fever: Management After Initial Antibiotic Therapy Failure

This protocol addresses the specific clinical scenario of a patient with ADPKD who develops a liver cyst infection and has not responded adequately to first-line antibiotic treatment.

The presenting picture is ADPKD with an infected liver cyst — defined by fever above 38.0°C, abdominal pain, and either serum C-reactive protein ≥50 mg/l or white blood cell count above 11 × 10⁹/l. When this presentation persists or worsens despite antibiotic treatment, a different management strategy is required.

Previous Treatment — Failure Condition

First-line management of liver cyst infection in ADPKD uses empirical antibiotic therapy: a third-generation intravenous cephalosporin with or without a fluoroquinolone, followed by an oral fluoroquinolone. The target is clinical response within 48–72 hours — specifically, temperature falling below 38.0°C and a measurable decrease in C-reactive protein. When those targets are not met, escalation to this next step is indicated.

Next-Step Approach

When antibiotics alone are insufficient, management shifts to a procedural intervention that directly addresses the infected cyst — with the approach determined by the location and accessibility of the cyst involved.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.kint.2024.07.010

Empirical antibiotic treatment of liver cyst infections should target gram-negative bacteria in the Enterobacteriaceae family.

Placement of a percutaneous drain should be considered for failure to improve, worsening symptoms, or presence of the risk factors listed, and the drain should be kept in place until drainage stops.

In the case of deep cysts for which percutaneous drainage is not feasible, surgical drainage may be necessary.

View source ↗